- Location
Multiple Sclerosis
"-
Granalix Launches Pomegranate Oil-Based Food Additive
Oct 8, 2016Granalix BioTechnologies has commercially launched a patented pomegranate oil based food supplement which is claimed to prevent neurodegeneration diseases. Branded as GranaGard, the food additive is produced by Supherb and is priced at ...
-
Rutherfords Launches Dressage Fundraising Event
Sep 29, 2016Department store Rutherfords of Morpeth is planning a fundraising event for disabled Northumberland horsewoman Gayle Bloomfield to help keep her bid for 2017 glory on track on Monday, 24th October 24, in association with cosmetics brand, ...
-
Rayvio and Boston University Expand UV LED Research to Combat Vitamin D Deficiency Disorders
Aug 1, 2016Health and hygiene company RayVio Corp of Haywood, CA, USA, which is commercializing deep-ultraviolet (UV) LEDs and consumer disinfection solutions, is expanding a research program with Boston University to develop new treatments for ...
-
Social Inclusion Project Identifies Furniture Workplace Potential
Mar 23, 2016The BFM is part of an industry consortium that manages Working Tri21, an EU-funded project which aims to enhance the social inclusion of people suffering from disabilities by integrating them into the job market, specifically in the ...
-
Drinking Coffee May Be Associated with a Lower Risk of Developing MS
Mar 5, 2015Drinking coffee may be associated with a lower risk of developing multiple sclerosis (MS), according to a study from Johns Hopkins University School of Medicine in Baltimore. The study, published in February 2015 and to be presented at ...
Tags: Drinking Coffee, Coffee
-
Google Medtech News
Feb 2, 2015Posted in Mobile Health by Chris Newmarker on January 30, 2015 Why would two women who visit the doctor with identical early symptoms of multiple sclerosis have vastly different outcomes 10 years later? That’s what pharmaceutical ...
-
Toy Enthusiast Made It His Mission to Rescue The Toys From Failing Toys Shops
Mar 11, 2014Toy enthusiast made it his mission to rescue the toys from failing toys shops or broken stock departments of factories as a child. A collection of over 2,000 vintage tin plate toys saved from struggling shops and factories is tipped to ...
Tags: Vintage Toys, Auction, Toys
-
A New Study Describes The Complexity of The New T Cell Repertoire
Mar 4, 2014A new study describes the complexity of the new T cell repertoire following immune-depleting therapy to treat multiple sclerosis, improving our understanding of immune tolerance and clinical outcomes. In the Immune Tolerance Network's ...
Tags: Immune System Reconstitutes Itself, Immune-Depleting Therapy
-
MS Might Be Detectable in The Blood of People with The Disease Before Symptoms Appear
Feb 27, 2014An antibody linked with multiple sclerosis (MS) might be detectable in the blood of people with the disease before symptoms appear, a new study indicates. The findings could lead to earlier diagnosis and treatment of the central nervous ...
Tags: earlier diagnosis and treatment, blood samples, protein
-
MRF Announced It Has Entered a Cooperative Research and Development Agreement with The NIN
Feb 10, 2014The Myelin Repair Foundation (MRF) today announced it has entered a Cooperative Research and Development Agreement (CRADA) with the National Institutes of Health (NIH) to assess MRF-008, as a potential therapeutic for multiple sclerosis ...
Tags: Multiple Sclerosis, Sclerosis, Myelin
-
Teva and Active Biotech Have Announced That Both Companies Remain
Feb 10, 2014Teva Pharmaceutical Industries and Active Biotech have announced that both companies remain committed to the Nerventra(laquinimod)clinical development program for multiple sclerosis(MS)following the announcement of a negative opinion for ...
Tags: Medicine, clinical studies, Nerventra
-
Teva Pharmaceuticals Received Approval for sNDA for Three-Times-a-Week COPAXONE 40mg/mL
Feb 7, 2014Teva Pharmaceuticals has received approval from the US Food and Drug Administration (FDA) for its supplemental new drug application (sNDA) for three-times-a-week COPAXONE 40mg/mL, a new dose of COPAXONE. COPAXONE (glatiramer acetate ...
-
Health Care Reform Survives a Lawsuit
Jan 21, 2014The New York Times: Health Care Reform Survives A Lawsuit A long-shot lawsuit that could have damaged the effectiveness of health care reform got a well-deserved brushoff from a federal district judge on Wednesday. The suit was brought ...
Tags: New York Times, Alemtuzumab, Maternity Leave, FDA
-
FAMPYRA Has Been Made Available in Ireland for The Symptomatic Treatment
Jan 16, 2014Biogen Idec today announced that FAMPYRA(prolonged-release fampridine tablets) has been made available in Ireland for the symptomatic treatment of walking impairment in adults with Multiple Sclerosis (MS). FAMPYRA is a prescription drug and ...
Tags: FAMPYRA, HSE, Biogen Idec, Named Patient Supply
-
"Microparticle" Therapy Might Significantly Reduce The Damage Caused by a Heart Attack
Jan 16, 2014Quick treatment with a new "microparticle" therapy might significantly reduce the damage caused by a heart attack, according to a new study conducted in mice. After a heart attack, much of the damage to the heart muscle is caused by ...
Related Products
-
DMF 99% C6h8o4 Dimethyl Fumarate for Multiple Sclerosis Ms Treatment 624-49-7
-
Trusted Glatiramer Acetate 147245-92-9 for Patients with Multiple Sclerosis
-
Carbamazepine Tablets to Relieve Multiple Sclerosis, Peripheral Diabetic Neuralgia
-
High Quality Dimethyl Fumarate Use for Multiple Sclerosis CAS No.: 624-49-7
